134 related articles for article (PubMed ID: 2960890)
1. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
[TBL] [Abstract][Full Text] [Related]
2. Feeder cells enhance oncolytic and proliferative activity of long-term human bone marrow interleukin-2 cultures and induce different lymphocyte subsets.
Fuchshuber PR; Lotzová E
Cancer Immunol Immunother; 1991; 33(1):15-20. PubMed ID: 2021955
[TBL] [Abstract][Full Text] [Related]
3. Persistent augmentation of natural-killer- and T-cell-mediated cytotoxicity in peripheral blood mononuclear cells pulsed in vitro with high-dose recombinant interleukin-2 prior to culturing with a low maintenance dose.
Palmer PA; Scharenberg JG; von Blomberg BM; Stam AG; Meijer CJ; Roest GJ; Franks CR; Scheper RJ
Cancer Immunol Immunother; 1994 Jul; 39(1):34-40. PubMed ID: 8044824
[TBL] [Abstract][Full Text] [Related]
4. GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo.
Lim O; Lee Y; Chung H; Her JH; Kang SM; Jung MY; Min B; Shin H; Kim TM; Heo DS; Hwang YK; Shin EC
PLoS One; 2013; 8(1):e53611. PubMed ID: 23326467
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of stimulation of human natural killer cytotoxicity by arabinogalactan from Larix occidentalis.
Hauer J; Anderer FA
Cancer Immunol Immunother; 1993; 36(4):237-44. PubMed ID: 8439987
[TBL] [Abstract][Full Text] [Related]
6. Activation of human T-helper/inducer cell, T-cytotoxic cell, B-cell, and natural killer (NK)-cells and induction of natural killer cell activity against K562 chronic myeloid leukemia cells with modified citrus pectin.
Ramachandran C; Wilk BJ; Hotchkiss A; Chau H; Eliaz I; Melnick SJ
BMC Complement Altern Med; 2011 Aug; 11():59. PubMed ID: 21816083
[TBL] [Abstract][Full Text] [Related]
7. Interferon beta enhances the natural killer activity of patients with bladder carcinoma.
Moltó L; Carballido J; Manzano L; Olivier C; Lapeña P; Alvarez-Mon M
Cancer Immunol Immunother; 1994 Jun; 38(6):406-10. PubMed ID: 8205562
[TBL] [Abstract][Full Text] [Related]
8. Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) depresses natural killer (NK) cell activity.
Keong A; Herman J; Rabson AR
Cancer Immunol Immunother; 1983; 15(3):183-7. PubMed ID: 6555060
[TBL] [Abstract][Full Text] [Related]
9. Imaging immune surveillance of individual natural killer cells confined in microwell arrays.
Guldevall K; Vanherberghen B; Frisk T; Hurtig J; Christakou AE; Manneberg O; Lindström S; Andersson-Svahn H; Wiklund M; Önfelt B
PLoS One; 2010 Nov; 5(11):e15453. PubMed ID: 21103395
[TBL] [Abstract][Full Text] [Related]
10. Differences in nature killer cell response and interference with mitochondrial DNA induced apoptosis in moxifloxacin environment.
Wang M; Wu H; Jiang W; Ren Y; Yuan X; Wang Y; Zhou J; Feng W; Wang Y; Xu T; Zhang D; Fang Y; He C; Li W
Int Immunopharmacol; 2024 May; 132():111970. PubMed ID: 38608472
[TBL] [Abstract][Full Text] [Related]
11. Expression of viral CD45 ligand E3/49K on porcine cells reduces human anti-pig immune responses.
Pokoyski C; Baars W; Windheim M; Reubold TF; Zischke J; Brinkmann A; Kay-Fedorov PC; Schwinzer R
Sci Rep; 2023 Oct; 13(1):17218. PubMed ID: 37821577
[TBL] [Abstract][Full Text] [Related]
12. Single Cell Transcriptome Analysis of Peripheral Blood Mononuclear Cells in Freshly Isolated versus Stored Blood Samples.
Qu HQ; Kao C; Garifallou J; Wang F; Snyder J; Slater DJ; Hou C; March M; Connolly JJ; Glessner JT; Hakonarson H
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672883
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models.
Boulay A; Trabanelli S; Boireau S; Boyer-Clavel M; Nisole S; Romero P; Jandus C; Beignon AS; Arhel NJ
Immunohorizons; 2023 Mar; 7(3):243-255. PubMed ID: 37000496
[TBL] [Abstract][Full Text] [Related]
14. Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets.
Jin P; Wang E; Provenzano M; Deola S; Selleri S; Ren J; Voiculescu S; Stroncek D; Panelli MC; Marincola FM
J Transl Med; 2006 Jun; 4():26. PubMed ID: 16805915
[TBL] [Abstract][Full Text] [Related]
15. A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells.
Carney EF
Nat Rev Nephrol; 2024 Apr; 20(4):203. PubMed ID: 38418898
[No Abstract] [Full Text] [Related]
16. Osteoclasts and Probiotics Mediate Significant Expansion, Functional Activation and Supercharging in NK, γδ T, and CD3+ T Cells: Use in Cancer Immunotherapy.
Kaur K; Jewett A
Cells; 2024 Jan; 13(3):. PubMed ID: 38334605
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells.
Reina-Ortiz C; Mozas MP; Ovelleiro D; Gao F; Villalba M; Anel A
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686362
[TBL] [Abstract][Full Text] [Related]
18. Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations.
Allan DSJ; Wu C; Mortlock RD; Chakraborty M; Rezvani K; Davidson-Moncada JK; Dunbar CE; Childs RW
Mol Ther Oncolytics; 2023 Mar; 28():74-87. PubMed ID: 36699615
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic natural killer cell therapy.
Berrien-Elliott MM; Jacobs MT; Fehniger TA
Blood; 2023 Feb; 141(8):856-868. PubMed ID: 36416736
[TBL] [Abstract][Full Text] [Related]
20. Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing.
Gurney M; Kundu S; Pandey S; O'Dwyer M
Front Immunol; 2022; 13():802906. PubMed ID: 35222382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
